0001437749-23-034227.txt : 20231212 0001437749-23-034227.hdr.sgml : 20231212 20231212170517 ACCESSION NUMBER: 0001437749-23-034227 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231208 FILED AS OF DATE: 20231212 DATE AS OF CHANGE: 20231212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LeMaitre George W CENTRAL INDEX KEY: 0001365737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 231481949 MAIL ADDRESS: STREET 1: 342 BUNKER HILL STREET, #2B CITY: CHARLESTOWN STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rdgdoc.xml FORM 4 X0508 4 2023-12-08 0001158895 LEMAITRE VASCULAR INC LMAT 0001365737 LeMaitre George W C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 1 Chairman and CEO 0 Common Stock 2023-12-11 4 S 0 22088 54.41 D 2269675 D Common Stock 2023-12-11 4 S 0 200 54.99 D 2269475 D Common Stock 2023-12-08 4 A 0 5032 0 A 2291763 D Stock Option (Right to Buy) 54.65 2023-12-08 4 A 0 26555 0 A 2023-12-08 2030-12-08 Common Stock 26555 26555 D The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $53.94 to $54.79. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $54.96 to $55.03. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. The exercise price of this option to the extent it is an incentive stock option is $60.12 per share, and the exercise price of this option to the extent it is a nonqualified stock option is $54.65 per share. This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. The expiration date of this option to the extent it is an incentive stock option is 12/8/2028, and the expiration date of this option to the extent it is a nonqualified stock option is 12/8/2030. /s/ David .Hissong 2023-12-12